| 发明名称 |
SIRNA AGAINST CBL-B AND OPTIONALLY IL-2 AND IL-12 FOR USE IN THE TREATMENT OF CANCER |
| 摘要 |
<p>The invention relates to a method for the immune activation of NK cells by the reduction or inhibition of the Cbl-b function in said cells. This stimulates the congenital immune system and thus permits the therapy of appropriate diseases.</p> |
| 申请公布号 |
CA2822114(A1) |
申请公布日期 |
2012.07.05 |
| 申请号 |
CA20112822114 |
申请日期 |
2011.12.27 |
| 申请人 |
APEIRON BIOLOGICS AG |
发明人 |
LAMETSCHWANDTNER, GUNTHER;LOIBNER, HANS;SCHUSTER, MANFRED;HASLINGER, ISABELLA;SEIDL, SANDRA |
| 分类号 |
A61K38/20;A61P35/00;C12N15/113 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
